IU School of Medicine awarded $36M NIH grant for Alzheimer’s disease drug discovery center
Indiana University School of Medicine has been awarded a grant expected to total $36 million over five years from the National Institutes of Health to launch a drug discovery center to accelerate the development of promising treatments for Alzheimer's disease. The initial focus of the center will be on the immune system, consistent with IU's Precision Health Grand Challenge initiative.
The center is a strategic partnership with the Purdue Institute for Drug Discovery. It is one of only two such multi-institution teams in the nation selected as part of a new federal program intended to "improve, diversify and reinvigorate the Alzheimer's disease drug development pipeline," according to the National Institute on Aging, which is part of the NIH and is funding the program.